Skip to main content
    T

    Telomir Pharmaceuticals, Inc. Common Stock (TELO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.42
    -0.06 (-12.04%)

    Market Cap: $35.44M

    Last updated: Nov 17, 2026 at 4:17 PM ET

    Telomir Pharmaceuticals, Inc. Common Stock (TELO) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Telomir Pharmaceuticals, Inc. Common Stock (TELO) has a market cap of $35.44M and an enterprise value of $30.92M. Its share count is up 121.57% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 12.74% below the market cap, as cash exceeds debt.

    Market Cap$35.44M
    Enterprise Value$30.92M
    Latest price (Nov 17, 2026)$0.42

    Key Dates

    The next earnings report is expected on Mar 15, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 15, 2027 (expected)
    Last Earnings DateNov 6, 2026
    Fiscal Year EndSeptember

    Share Statistics

    The share count rose 100.04% in the quarter ended Sep 30, 2026 and grew 52.40% a year over 2 years.

    Shares Outstanding68.77M
    Shares Change (YoY)+121.57%
    Shares Change (QoQ)+100.04%
    Share Count Growth (2Y CAGR)+52.40%

    Price Statistics

    The stock is down 68.66% over 52 weeks and trades 58.42% below its 50-day average.

    Beta (1Y)1.72
    52-Week Change-68.66%
    1-Month Change-59.32%
    3-Month Change-63.84%
    6-Month Change-65.32%
    Total Return (1Y)-68.66%
    Max Drawdown (1Y)-71.60%
    Max Drawdown (3Y)-96.44%
    Sharpe Ratio (1Y)-1.78
    Correlation with SPY (1Y)0.34
    50-Day Average$1.01
    200-Day Average$1.18
    52-Week Range$0.44 to $1.58
    RSI (14 Days)11.0
    Average Volume (20 Days)165.29K

    Price chart

    Financial Position

    Current assets cover 19.60x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio19.60x
    Quick Ratio19.60x
    Debt / Equity0.00x
    Interest Coverage-722.27x

    Returns and Efficiency

    Return on equity is -124.39% and return on assets is -118.05% over the last 12 months.

    Return on Equity (ROE)-124.39%
    Return on Assets (ROA)-118.05%
    Return on Capital Employed (ROCE)-124.28%

    Scores

    TELO has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Operating Income-$5.69M
    Pretax Income-$5.48M
    Net Income-$5.48M
    EBITDA-$5.47M
    EBIT-$5.47M
    Reported EPS (TTM)-$0.89

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 94.83% of the $4.64M in total assets.

    Cash and Equivalents$4.52M
    Total Debt$0
    Net Cash$4.52M
    Net Cash Per Share$0.07
    Working Capital$4.40M
    Shareholder Equity$4.40M
    Book Value Per Share$0.06
    Total Assets$4.64M
    Total Liabilities$236.75K

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $3 of capital spending, operating cash flow left -$4.57M of free cash flow.

    Operating Cash Flow-$4.57M
    Capital Expenditures$3
    Free Cash Flow-$4.57M
    FCF Per Share-$0.06

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About TELO

    What is TELO's market cap?

    Telomir Pharmaceuticals, Inc. Common Stock has a market cap of $35.44M. Its enterprise value, which adds debt and subtracts cash, is $30.92M.

    How many shares of TELO are outstanding?

    Telomir Pharmaceuticals, Inc. Common Stock has 68.77M shares outstanding. The count is up 121.57% from a year earlier.

    Does TELO pay a dividend?

    No. Telomir Pharmaceuticals, Inc. Common Stock does not pay a dividend.

    How much debt does TELO have?

    Telomir Pharmaceuticals, Inc. Common Stock has $0 of total debt and $4.52M of cash and equivalents, a net cash position of $4.52M.